NCT00546481View on ClinicalTrials.gov

A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Anemia
Interventions
DRUG

methoxy polyethylene glycol-epoetin beta [RO0503821, Mircera]

0.6 micrograms/kg every 2 weeks

DRUG

Epoetin

As prescribed, iv, 3 times weekly

Trial Locations (7)

431-070

Gyeonggi-do

110-744

Seoul

134-701

Seoul

135-710

Seoul

137-701

Seoul

405-760

Seoul

463-802

Sungnam

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00546481 - A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients. | Biotech Hunter | Biotech Hunter